How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives

Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial

(2015) Archana Singal et al.   Indian Journal of Dermatology Venereology & Leprology

Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies

(2015) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes

(2015) Sergio Schalka et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails

(2014) A. Shemer et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails

(2014) A. Shemer et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A second look at efficacy criteria for onychomycosis: clinical and mycological cure

(2013) M. Ghannoum et al.   BRITISH JOURNAL OF DERMATOLOGY

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

(2013) Bárður Sigurgeirsson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Quality of life in patients with toenail onychomycosis

(2013) Danica Milobratović et al.   MYCOSES

Comparison of visual assessments versus planimetry assessments in a large-scale clinical trial of onychomycosis

(2012) Aditya K. Gupta et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

(2012) Boni E. Elewski et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study

(2012) L. Emtestam et al.   MYCOSES

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

(2011) B. Elewski et al.   BRITISH JOURNAL OF DERMATOLOGY

Therapeutic efficacy of topical OLEOZON® in patients suffering from onychomycosis

(2010) Silvia Menéndez et al.   MYCOSES

Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study

(2009) B. Amichai et al.   BRITISH JOURNAL OF DERMATOLOGY

The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis

(2009) AK Gupta et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis

(2009) R Baran et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day−1for a week)

(2008) Y. Takahata et al.   MYCOSES

Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability ofAgeratina pichinchensisExtract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox

(2008) Ofelia Romero-Cerecero et al.   PLANTA MEDICA